J Biomed Mater Res A, 2022 · DOI: 10.1002/jbm.a.37312 · Published: March 1, 2022
Damage to the nervous system can result in loss of sensory and motor function, paralysis, or even death. To facilitate neural regeneration and functional recovery, researchers have employed biomaterials strategies to address both peripheral and central nervous system injuries. Injectable hydrogels that recapitulate native nerve extracellular matrix are especially promising for neural tissue engineering because they offer more flexibility for minimally invasive applications and provide a growth-permissive substrate for neural cell types. Here, we explore the development of injectable hydrogels derived from decellularized rat peripheral nerves (referred to as “injectable peripheral nerve (iPN) hydrogels”), which are processed using a newly developed sodium deoxycholate and DNase (SDD) decellularization method.
The iPN hydrogel can be used as a delivery vehicle for drug-loaded microparticles, offering a combinatorial approach to neural injury therapies.
The iPN hydrogel can be a potential delivery vehicle for cell-based therapies, given its biocompatibility and support for Schwann cell viability.
The iPN hydrogel represents a promising biocompatible platform for the development of novel therapies for neural injury repair.